Lesley Russell
CIK: 0001374636
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (100.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
ENTA
ENANTA PHARMACEUTICALS INC
Director
Discretionary Trading P&L
Holdings
About Russell Lesley
Russell Lesley (SEC CIK 0001374636) files insider reports with the SEC as Director of ENANTA PHARMACEUTICALS INC (ENTA).
Signal8 holds 2 ownership filings by Russell Lesley, all Form 4s, filed between Mar 14, 2025 and Mar 13, 2026. Those filings report 2 transactions, from Mar 13, 2025 to Mar 11, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Russell Lesley's filings is in WATERTOWN, MA.
Recent filings by Russell Lesley
Other insiders filing for ENANTA PHARMACEUTICALS INC (ENTA)
- Rottinghaus Scott T., Chief Medical Officer
- Vance Terry, Director
- Peterson Kristine, Director
- Hata Yujiro S, Director
- FOLETTA MARK G, Director
- CARTER BRUCE L A, Director